<DOC>
	<DOCNO>NCT01988090</DOCNO>
	<brief_summary>This study do look difference , difference two different dos Vitamin D reduction joint/muscle pain ( arthralgia ) cause take anti-estrogen medication ( aromatase inhibitor ) breast cancer patient . The investigator hope learn take high dose Vitamin D good way prevent aromatase inhibitor arthralgia ( AIA ) .</brief_summary>
	<brief_title>High Dose Vitamin D v Standard Dose Vitamin D Study</brief_title>
	<detailed_description>Treatments anti-estrogen agent hormone receptor positive breast cancer efficacious systemic therapy , aromatase inhibitor ( AI 's ) consider active anti-estrogen therapy early stage breast cancer . But , use treatment show cause musculoskeletal ( joint/muscle ) side effect sometimes cause patient discontinue use . Also , Vitamin D deficiency well know cause wide array musculoskeletal issue . There evidence Vitamin D supplementation may help prevent arthralgia AI 's . Therefore , investigator want see give high dose Vitamin D could decrease incidence AIA compare standard dose Vitamin D. The investigator believe could possibly result patient continue treatment AI therapy hormone receptor positive breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>All participant must female least 21 year age Signed informed consent Patients must histologically confirm stage IIII breast carcinoma positive Estrogen Receptor ( ER ) and/or Progesterone Receptor ( PR ) . Postmenopausal Beginning adjuvant aromatase inhibitor therapy , previous use within last 6 week Bisphosphonates allow treat investigator¡¦s discretion Performance status ( WHO/ECOG scale ) 02 . History kidney stone Hypercalcemia baseline , define correct calcium great laboratory 's normal parameter History either symptomatic hypercalcemia hyperparathyroidism , treat investigator 's discretion Baseline Vitamin D level great 50 ng/mL Inability unwillingness comply , follow study procedure . Currently take Phenytoin phenobarbital 7 Currently take cholestyramine orlistat Malabsorption syndrome , Crohn 's disease Prohibited Therapies : Patients may take additional Calcium Vitamin D aside study medication . Patients cholestyramine orlistat allow trial . Also , patient take phenytoin phenobarbital allow trial either interaction Vitamin D antiepileptic medication .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Hormone Receptor Positive</keyword>
	<keyword>Vitamin D</keyword>
</DOC>